American Society of Clinical Oncology

SHERPA: White

People

  1. Motzer
    Motzer
  2. Scher
    Scher
  3. O'Reilly
    O'Reilly
  4. Saltz
    Saltz
  5. Bajorin
    Bajorin
  6. Kris
    Kris
  7. Hudis
    Hudis
  8. Morris
    Morris
  9. Rosenberg
    Rosenberg
  10. Robson
    Robson

Groups

  1. Department of Medicine (6335)
  2. Solid Tumor Oncology Division (5476)
  3. Survivorship Research (1978)
  4. Genitourinary Oncology Service (1751)
  5. Surgery (1623)
  6. Epidemiology and Biostatistics (1468)
  7. GSK Faculty (1374)
  8. Population Sciences Research Program (1357)
  9. Gastrointestinal Oncology Service (1342)
  10. Hematologic Malignancies, Division of (1269)
Search Within
Formats
  1. Meeting Abstract (6252)
  2. Journal Article (2560)
  3. Editorial (73)
  4. Review (65)
  5. Guidelines (54)
  6. Correspondence (47)
  7. Miscellaneous (4)
  8. Conference Paper (3)
Groups
  1. Department of Medicine (6335)
  2. Solid Tumor Oncology Division (5476)
  3. Survivorship Research (1978)
  4. Genitourinary Oncology Service (1751)
  5. Surgery (1623)
  6. Epidemiology and Biostatistics (1468)

More Groups

People
  1. Robert Motzer (447)
  2. Howard Scher (334)
  3. Eileen O'Reilly (303)
  4. Leonard Saltz (283)
  5. Dean Bajorin (278)
  6. Mark Kris (252)

More People

Years
  1. 2025 (166)
  2. 2024 (554)
  3. 2023 (580)
  4. 2022 (554)
  5. 2021 (504)
  6. 2020 (539)

More Years

Publications
  1. Journal of Clinical Oncology (8596)
  2. JCO Precision Oncology (165)
  3. Journal of Oncology Practice (124)
  4. American Society of Clinical Oncology Educational Book (112)
  5. JCO Clinical Cancer Informatics (53)
  6. ASCO Connection (3)

More Publications

Results (9058)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • A phase 1/2 study of REGN7075 (EGFRxCD28 costimulatory bispecific antibody) in combination with cemiplimab (anti-PD-1) in patients with advanced solid tumors, including colorectal cancer: Trial in progress update
    Meeting Abstract

    Segal, N. H.; Girda, E.; Sohal, D.; Lakhani, N. J.; Olszanski, A. J.; Fong, L.; Han, H.; Casey, K. A.; Li, S.; Ganguly, S.; more...
    Journal of Clinical Oncology (2024)

    Fulltext@MSK | Save
  • Phase 1b/2, open-label dose-escalation and -expansion study evaluating trastuzumab deruxtecan (T-DXd) monotherapy and combinations in patients (pts) with HER2+ and HER2-low gastric cancer (GC): DESTINY-Gastric03 (DG-03)
    Meeting Abstract

    Janjigian, Y. Y.; Raoufmoghaddam, S.; Sztachelska, M.; Winter, M.; Das, S.
    Journal of Clinical Oncology (2024)

    Fulltext@MSK | Save
  • A phase 1b/2 study to evaluate the safety and efficacy of TTI-101 as monotherapy and in combination in advanced hepatocellular carcinoma
    Meeting Abstract

    Dayyani, F.; Baretti, M.; Lee, S. S.; He, A. R.; Kim, R. D.; Lin, B. S. L.; Enzler, T.; Al Hallak, M. N.; Ulahannan, S. V.; Davis, S. L.; more...
    Journal of Clinical Oncology (2024)

    Fulltext@MSK | Save
  • PRECISION 1: A phase 2, multicenter, open-label basket trial of nab-sirolimus for malignant solid tumors harboring pathogenic inactivating alterations in TSC1 and TSC2
    Meeting Abstract

    Deming, D. A.; Kwiatkowski, D. J.; Ding, L.; Schmid, A. N.; Navarro, W. H.; Ahnert, J. R.; Iyer, G.
    Journal of Clinical Oncology (2024)

    Fulltext@MSK | Save
  • AMPLIFY-7P: Phase 1 and randomized phase 2 study of amphiphile immunotherapy ELI-002 7P as adjuvant treatment for subjects with G12D, G12R, G12V, G12C, G12A, G12S and G13D Kirsten rat sarcoma (KRAS)-mutated pancreatic ductal adenocarcinoma
    Meeting Abstract

    Wainberg, Z. A.; Chung, V.; Devoe, C. E.; George, T. J.; Welkowsky, E.; Kheoh, T.; Haqq, C. M.; Pant, S.; O'Reilly, E. M.
    Journal of Clinical Oncology (2024)

    Fulltext@MSK | Save
  • Peak study: A phase 3, randomized, open-label multicenter clinical study of bezuclastinib (CGT9486) and sunitinib in combination versus sunitinib in patients with gastrointestinal stromal tumors (GIST)
    Meeting Abstract

    Heinrich, M. C.; Somaiah, N.; Trent, J. C.; Wilky, B. A.; Burgess, M. A.; Singh, A. S.; Attia, S.; Agulnik, M.; Tap, W. D.; Bauer, S.; more...
    Journal of Clinical Oncology (2024)

    Fulltext@MSK | Save
  • A novel classification of small bowel adenocarcinoma based on a hidden genome classifier: A multi-institutional study
    Meeting Abstract

    Schleimer, L. E.; Ethun, C. G.; Court, C.; Chou, J. F.; McIntyre, S. M. H.; Walch, H. S.; Sigel, C. S.; Sharib, J.; Masoud, S.; Chen, W.; more...
    Journal of Clinical Oncology (2024)

    Fulltext@MSK | Save
  • Durable efficacy of selpercatinib in patients with RET fusion plus solid tumors, with a focus on GI tumors: LIBRETTO-001
    Meeting Abstract

    Subbiah, V.; Drilon, A. E.; Sukrithan, V.; Spira, A. I.; Robinson, B.; Deschler-Baier, B.; Barker, S.; Lin, Y.; Szymczak, S.; Ohe, Y.
    Journal of Clinical Oncology (2024)

    Fulltext@MSK | Save
  • EMERALD-1: A phase 3, randomized, placebo-controlled study of transarterial chemoembolization combined with durvalumab with or without bevacizumab in participants with unresectable hepatocellular carcinoma eligible for embolization
    Meeting Abstract

    Lencioni, R.; Kudo, M.; Erinjeri, J.; Qin, S.; Ren, Z.; Chan, S.; Arai, Y.; Heo, J.; Mai, A.; Escobar, J.; more...
    Journal of Clinical Oncology (2024)

    Fulltext@MSK | Save
  • Alliance A022101: A pragmatic randomized phase III trial evaluating total ablative therapy for patients with limited metastatic colorectal cancer - Evaluating radiation, ablation, and surgery (ERASur)
    Meeting Abstract

    Hitchcock, K.; Romesser, P. B.; Shi, Q.; Dixon, J. G.; Gholami, S.; White, S. B.; Wu, C.; Goulet, C. C.; Jee, K. W.; Wright, C. L.; more...
    Journal of Clinical Oncology (2024)

    Fulltext@MSK | Save